Clinical trial
High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Combination Chemotherapy in Treating Women With High-Risk Breast Cancer
NCT00002784
Study timeline
Study start (unknown)1996-06-01Date precision: month
Registry last updated2013-04-04
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Breast Cancerunresolved
Interventions
filgrastimBIOLOGICAL
CMF regimenDRUG
cyclophosphamideDRUG · verified · RxNorm: cyclophosphamide
doxorubicin hydrochlorideDRUG · verified · RxNorm: doxorubicin hydrochloride
epirubicin hydrochlorideDRUG · verified · RxNorm: epirubicin hydrochloride
fluorouracilDRUG · verified · RxNorm: fluorouracil
mesnaDRUG · verified · RxNorm: mesna
methotrexateDRUG · verified · RxNorm: methotrexate
tamoxifen citrateDRUG · verified · RxNorm: tamoxifen citrate
low-LET electron therapyRADIATION
low-LET photon therapyRADIATION
Sponsors & collaborators
ETOP IBCSG Partners Foundationlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00002784 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.